Key Takeaways:
Axon Enterprise (NASDAQ: AXON) reported first-quarter revenue of $807.3 million, beating Wall Street estimates driven by a surge in international demand for its Tasers and body cameras that prompted the company to raise its full-year outlook.
“I just think we’re showing up as more of a global company at this point,” President Josh Isner said on a conference call. “We’re showing up like a technology vendor that can help across a number of different product lines.”
The law-enforcement technology maker exceeded analyst expectations for both revenue and profit. The company’s performance marks a significant turnaround, delivering $29 million in operating income after five straight quarters of losses.
Shares of Axon jumped 7.6% to $415.14 on the news. The results provided some relief for investors after the stock had fallen 27% year-to-date over concerns about AI disruption and sustained operating losses.
The standout in Axon’s report was its performance outside the U.S. Non-U.S. revenue spiked 116% to $160.8 million from $74.3 million in the same quarter a year ago. International business now represents about 20% of the company’s total revenue, up from 12% last year. This growth was a key factor behind management’s decision to lift its full-year 2026 revenue growth forecast to a new range of 30% to 32%, up from a prior forecast of 27% to 30%.
Despite the strong report, some analysts remain cautious. UBS analyst Andrew Spinola maintained a Neutral rating on the shares, though he cut his price target to $440 from $570, reflecting the stock's recent decline. “We don’t think this will be enough to offset concerns about the company’s FCF generation and general concerns about AI disruption,” Spinola wrote.
The guidance increase suggests management is confident that demand, particularly from new international markets and for its AI-powered software offerings, will continue to strengthen. The company supplies police body cameras and drone systems to law enforcement agencies across North America, Europe, and Australia.
This article is for informational purposes only and does not constitute investment advice.
